Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by DuPree, E. L.
Right arrow Articles by Almasan, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by DuPree, E. L.
Right arrow Articles by Almasan, A.
[Cancer Research 64, 4390-4393, July 1, 2004]
© 2004 American Association for Cancer Research


Advances in Brief

Genotoxic Stress Induces Expression of E2F4, Leading to Its Association with p130 in Prostate Carcinoma Cells

Erica L. DuPree1,3, Suparna Mazumder1 and Alexandru Almasan1,2,3

Departments of 1 Cancer Biology and 2 Radiation Oncology, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, Ohio, and 3 Department of Chemistry, Cleveland State University, Cleveland, Ohio


    ABSTRACT
 Top
 ABSTRACT
 Introduction
 Materials and Methods
 Results and Discussion
 REFERENCES
 
The retinoblastoma (pRb), p107, and p130 pocket proteins bind to the E2F transcription factors to control gene expression. E2F4 protein levels increased and accumulated in the nuclei of prostate carcinoma cells subjected to ionizing radiation (IR). The IR-induced increase of E2F4 levels led to an increase in E2F4 binding to p130 but had no effect on E2F4/p107 or E2F5/p130 complexes. The increase in E2F4/p130 association after IR was observed in prostate carcinoma cells regardless of their sensitivity to androgens, but not in breast carcinoma cells. E2F4/p130 complex formation was dependent on dissociation of p130 from cyclin-dependent kinase 2 and p130 dephosphorylation. Disruption of E2F4 through small interfering RNA prevented p130/E2F4 complex formation and sensitized cells to IR-induced apoptosis, leading to caspase-3 activation, cleavage of its substrate, poly(ADP-ribose) polymerase, and nuclear condensation. The E2F4/p130 pocket protein complex emerges as a new target of radiation in prostate carcinoma cells.


    Introduction
 Top
 ABSTRACT
 Introduction
 Materials and Methods
 Results and Discussion
 REFERENCES
 
Prostate cancer is the most widely diagnosed cancer and the second cause of cancer death in North American men, affecting one third of all men > 50 years old (1) . Surgery and radiation therapy are considered the best treatments for differentiated, clinically localized cancers (2) . We have studied the changes that occur during the G1-S-phase progression of LNCaP C4-2 cells after ionizing radiation (IR), which is a prototypic genotoxic stress agent. Progression through the eukaryotic cell cycle is largely regulated by the E2F transcription factors. The expression of the genes that they control has been strongly implicated in or linked to the positive control of cellular proliferation (3) . There are seven known E2F family members, with E2F1–3 referred to as the "activating" E2Fs, and E2F4 and E2F5 referred to as the "repressive" E2Fs (4) .

The retinoblastoma tumor suppressor (pRb) and related pocket proteins, p107 and p130, were identified based on the structural similarity of their pocket domains and their binding to E2F transcription factors. The pRb protein primarily interacts with E2F1–4, p107 interacts with E2F4, and p130 interacts with both E2F4 and E2F5 (5 , 6) . Another distinguishing difference between the three pocket proteins is that, unlike pRb, p107 and p130 can stably associate with the cyclin/cyclin-dependent kinase (CDK) 2 kinase complexes without hindering their abilities to bind their respective E2F partners (3 , 7) . E2F/pocket protein complexes form predominantly in the nucleus. Repressor complexes containing E2F4/p130 and E2F5/p130 are formed in G0. In early G1, pRb binds to E2F1–4, and in late G1, E2F4 binds to p107 (4 , 5 , 7) . Phosphorylation of specific sites on the pocket proteins leads to inactivation of the repressive complexes, which promotes the release of E2Fs and S-phase progression (7) . It is believed that once E2F4 is released from its complex with p130, as a result of p130 phosphorylation, both cyclin/CDK2 and E2F1 are activated (8) , and E2F4 is exported out of the nucleus in a CRM-1-dependent manner (9) . It has been suggested that after DNA damage, the p53 tumor suppressor is induced to activate p21, a CDK inhibitor, which will inactivate the cyclin/CDK2 kinase activity. This, in turn, inhibits the release of E2F transcription factors from the pocket proteins, which blocks transcription of regulatory genes implicated in the G1-S-phase transition (10) .

Previous studies have revealed a critical role for the retinoblastoma susceptibility gene product, pRb, in the cell growth suppressive function after treatment with genotoxic agents (11 , 12) . pRb inactivation sensitizes cells to genotoxic stress; however, the role of related pocket proteins and their E2F partners in the response to genotoxic stress is not clear. To further assess the role of these proteins in the genotoxic stress response, we examined the effects of IR on E2F and partner pocket protein expression levels. Our data indicate that formation of the E2F4/p130 complex is specifically regulated by IR in prostate but not in breast cancer cells. Moreover, our data also suggest that the interaction between CDK2 and p130 is also affected by IR, which may be a result of the increased levels of E2F4 associated with p130, leading to a decrease in p130 phosphorylation and decreased cell viability. Small interfering RNA (siRNA)-mediated down-regulation of E2F4 prevents p130/E2F4 complex formation and sensitizes cells to IR-induced apoptosis.


    Materials and Methods
 Top
 ABSTRACT
 Introduction
 Materials and Methods
 Results and Discussion
 REFERENCES
 
Cell Culture and Treatments.
LNCaP prostate and MCF-7 breast cancer cells were obtained from American Type Culture Collection (Manassas, VA). C4-2, the androgen-hypersensitive derivative of LNCaP (13) , was a gift from Dr. W. Heston (Cleveland Clinic). All cells were grown in monolayer culture in RPMI 1640 containing 10% heat-inactivated fetal bovine serum (Invitrogen, Carlsbad, CA; Ref. 14 ). Cells were either left untreated or subjected to 10 Gy of {gamma}-irradiation (15) .

Western Blot Analysis.
Cells were collected at the indicated times after IR. Protein samples in SDS-containing lysis buffer were loaded on 6–10% acrylamide gels (30 µg/lane). After electrophoresis, proteins were transferred onto a nitrocellulose membrane and blocked with 5% nonfat milk. The membrane was incubated for 1.5 h at room temperature with primary antibodies for p130 (sc-317; 1:100), p107 (sc-318; 1:100), E2F4 (sc-866; 1:200), and caspase-3 p20 (sc-1748; 1:500) from Santa Cruz Biotechnology and poly(ADP-ribose) polymerase (1:500) from Biomol, followed by a 1-h incubation with secondary horseradish peroxidase-conjugated antibodies (Amersham Biosciences). ß-Actin (1:500; Sigma Chemical Co., St. Louis, MO) was used as a loading control. The membrane was incubated in Lumiglo Chemiluminescent Substrate (Kirkegaard and Perry Laboratories) and visualized by exposure to X-ray film (Eastman Kodak). All other chemicals, unless otherwise specified, were obtained from Sigma Chemical Co.

Immunocytochemistry.
Control and treated C4-2 cells grown on coverslips in 6-well plates were fixed using a 3.7% formaldehyde/PBS solution. After three washes with 1x PBS for 5 min each, coverslips were incubated to block nonspecific binding with 2% goat serum, 0.3% Triton X-100, and 1x PBS for 10 min, followed by anti-E2F4 antibody (1:400) for 1 h. After three additional washes with PBS for 5 min, the cell monolayers were incubated with an Alexa Fluor 488-conjugated anti-rabbit secondary antibody (1:1000; Molecular Probes, Eugene, OR) for 45 min. The coverslips were washed three times, mounted with Vectashield containing 4',6-diamidino-2-phenylindole (Vector Laboratories, Burlingame, CA), and observed under confocal microscopy (Leica TCS-SP2, Heidelburg, Germany).

Immunoprecipitation Analysis.
Control and irradiated cells were lysed as described above, except that 0.1% NP40 was substituted. p130, E2F4, E2F5 (sc-999), and CDK2 (sc-6248) primary antibodies (0.2 µg/µl each; Santa Cruz Biotechnology) were used for immunoprecipitation as well as 15 µl of protein A/G-agarose (Oncogene) beads. The beads were washed in lysis buffer and boiled in 30 µl of Laemlli buffer; the entire sample was loaded on a SDS-polyacrylamide gel and processed by Western blotting. The membranes were immunoblotted with anti-p130, anti-CDK2, and anti-E2F4 primary antibodies and visualized as described above, except that the IgG heavy chain was used as a loading control.

siRNA Transfection.
Oligonucleotides corresponding to the U15641 e2f4 NCBI sequence (16) at positions 904–924, 74–94, and 651–671 (all followed by 5'-CCC-TGT-CTC-3' for annealing to the T7 promoter sequence) were used to generate sie2f4-1, -2, and -3, respectively. siRNAs were generated using the Silencer siRNA Construction Kit (Ambion) as described previously (14) . C4-2 cells were plated into a 24-well plate. At 24 h after transfection with Oligofectamine (Invitrogen) and 100–200 nM siRNA, cells were subjected to irradiation. They were then collected, lysed, and analyzed for protein expression by immunoblotting. Cell death was determined by the Hoechst 33258 staining (14) . After IR, C4-2 cells (attached and in suspension) were pooled and washed with serum-free RPMI 1640. An aliquot of the resuspended cells was incubated with Hoechst 33258 (10 µg/ml) for 1 min before being examined and scored under UV fluorescence microscopy (~200–300 cells/experimental sample). Each experiment, with the exception of the reagent-only control, was performed on six replicates. The sigapdh (glyceraldehyde-3-phosphate dehydrogenase) was generated in the same fashion as the sie2f4 siRNAs, with sense and antisense strands provided by Ambion.


    Results and Discussion
 Top
 ABSTRACT
 Introduction
 Materials and Methods
 Results and Discussion
 REFERENCES
 
Radiation Induces Changes in E2F4 and p130 Expression.
Examination of the IR response in prostate carcinoma C4-2 cells revealed that the expression level of E2F4 protein was elevated during a 16–24-h period (Fig. 1A)Citation . The levels of the phosphorylated form of p130 (p-p130), however, decreased in a time-dependent manner, whereas the unphosphorylated form of p130 was elevated. These changes were specific for p130 because at the same time, the levels of p107 did not increase and, in fact, slightly decreased beginning at 8 h after radiation treatment. These data suggest that both E2F4 expression and p130 phosphorylation are regulated by genotoxic stress. The localization of E2F4 before and after IR was examined next in C4-2 cells that were subjected to immunocytochemical staining at 24 h post-IR (Fig. 1B)Citation . E2F4 was present diffusely in both the cytoplasm and nuclei of the control (unirradiated) cells. In contrast, E2F4 was localized predominantly to the nuclei after IR. Because E2F4, which can form an active complex with p130, is considered to be a repressing E2F, our results indicate the possible role of E2F4/p130 in mediating the radiation-induced cell growth suppression and changes in gene expression.



View larger version (72K):
[in this window]
[in a new window]
 
Fig. 1. Changes in E2F4 and p130 protein after {gamma}-irradiation. A, C4-2 cells were collected at the indicated times after 10 Gy of ionizing radiation. Cellular lysates were loaded on 6% SDS-polyacrylamide gels and subjected to Western blotting analysis with anti-E2F4, anti-p107, anti-p130, and anti-ß-actin antibodies. B, E2F4 localization was detected using immunocytochemical staining before and after ionizing radiation as described in "Materials and Methods." Representative areas were photographed using a x63 lens and confocal microscopy.

 
IR Induces E2F4/p130 Complex Formation.
Examination of E2F4/p130 complex formation in irradiated cells revealed that the level of p130 in E2F4 immunoprecipitates increased starting at 8 h and continued up through 24 h postirradiation (Fig. 2A)Citation . At the same time, the E2F5 association with p130 remained relatively unaffected, as did the association between E2F4 and p107 (data not shown). The amount of E2F4 immunoprecipitated also increased (Fig. 2C)Citation , which parallels the IR-induced increase of E2F4 protein levels (Fig. 1A)Citation . These data suggest that IR causes increased levels and nuclear localization of E2F4 as well as p130 dephosphorylation, all of which contribute to E2F4/p130 complex formation. To further determine the generality of E2F4/p130 complex formation after IR, we examined the specificity of this response in several other tumor cell lines (Fig. 2B)Citation . C4-2 cells are androgen hypersensitive (17) , whereas the parental LNCaP cells are androgen dependent. As in C4-2 cells, the IR-induced formation of the E2F4/p130 complex was also dramatically elevated after irradiation of LNCaP cells. In contrast, no such response was observed after treatment of MCF-7 breast carcinoma cells. The reciprocal immunoprecipitation, which examined the levels of E2F4 in p130 immunoprecipitates, gave very similar results (Fig. 2D)Citation . These data indicate that the E2F4/p130 association after IR may be a prostate tumor cell type-specific response to IR, which is independent of the androgen sensitivity of these cells.



View larger version (69K):
[in this window]
[in a new window]
 
Fig. 2. Ionizing radiation (IR) induces association of E2F4 and p130. A, control and irradiated C4-2 cells were subjected to immunoprecipitation (IP) using anti-E2F4 and anti-E2F5 antibodies. These samples were then subjected to Western blot analysis using the anti-p130 antibody. B, C4-2, LNCaP, and MCF-7 cells were collected at 0 and 24 h after IR and lysed. Immunoprecipitations and immunoblots were carried out with anti-E2F4 and anti-p130 antibody, respectively. C, control and irradiated C4-2 cells, 0 and 24 h after IR, were subjected to immunoprecipitations followed by immunoblots with anti-E2F4 and anti-p130 antibodies. D, experiments similar to those described in B were performed, except that pull-down was with anti-p130, and immunoblot was with anti-E2F4. All samples were run on an 8% SDS-PAGE gel and subjected to Western blotting with the respective antibodies. The IgG heavy chain (H.C.) was used as a loading control.

 
It has been reported that the p130/E2F4 repressor complex binds to the Cyclin E/CDK2 complex (7 , 8 , 10 , 18) . This interaction has been suggested to facilitate the phosphorylation of p130 and the subsequent release of E2F4, thus leading to the activation of E2F-responsive genes and inhibition of growth suppression (19) . Examining the levels of p130 in CDK2 immunoprecipitates indicated a stable p130/CDK2 complex before irradiation, an association that persisted up to at least 8 h after treatment (Fig. 3A)Citation . However, at 16 h after IR, this association was dramatically decreased because very little p130 remained in complex with CDK2. Decreased levels of p130 association with CDK2 were observed up to at least 72 h (data not shown). The levels of CDK2 immunoprecipitated did not change (Fig. 3B)Citation . These observations, in conjunction with the decrease of phosphorylated p130 protein expression (Fig. 1A)Citation , suggest that IR causes a decrease in p130 phosphorylation due to the increased association between p130 and E2F4.



View larger version (44K):
[in this window]
[in a new window]
 
Fig. 3. Ionizing radiation induces inhibition of cyclin-dependent kinase (CDK) 2 association with p130. C4-2 cells were collected at 0–24 h after ionizing radiation. The cells were then lysed and subjected to immunoprecipitation using anti-CDK2 antibody. A, time course of p130/CDK2 association. Samples were then subjected to Western blot analysis using anti-p130 antibody. B, the decrease of p130 levels is not dependent on levels of CDK2. Similar experiments were performed, except that samples were subjected to Western blot analysis using anti-p130 and anti-CDK2 antibodies. The IgG heavy chain (H.C.) was used as a loading control.

 
E2F4 Down-Regulation Inhibits IR-Induced E2F4/p130 Complex Formation and Sensitizes C4-2 Cells to IR.
To directly examine the role of E2F4 in the IR response, we used siRNAs that were targeted against the e2f4 gene to inhibit protein expression. Of the three siRNAs targeted to e2f4 that we have screened in C4-2 cells, sie2f4-1 was the most effective. After transient transfection, the E2F4 protein expression level was substantially down-regulated by sie2f4-1 to reach ~30% of what was found in untreated cells (Fig. 4A)Citation . We then used sie2f4-1 to determine the effect of E2F4 down-regulation on IR-induced E2F4/p130 complex formation (Fig. 4B)Citation . In control cells, we confirmed the increase in E2F4 association with p130, observed above, at the 24 h time point. However, in cells that were transfected with sie2f4-1, this association was totally inhibited. This suggests that sie2f4-1 is effective in down-regulating e2f4 expression and, as a result, the E2F4 protein that is found in association with p130 after IR. These data also indicate that there is a pool of E2F4 protein that does not form a complex with p130; however, the role of this free form of E2F4 has not been determined.



View larger version (35K):
[in this window]
[in a new window]
 
Fig. 4. Down-regulation of E2F4 protein expression sensitizes cells to ionizing radiation (IR). Small interfering RNAs (siRNAs) targeting e2f4 were synthesized by in vitro transcription using oligonucleotides and the Ambion siRNA construction protocol as described in "Materials and Methods." C4-2 cells were transfected in 24-well plates with Oligofectamine and 100–200 nM siRNA. A, E2F4 expression after transfection with e2f4-targeted siRNAs was determined by immunoblotting with anti-E2F4 antibody and, as a control, ß-actin. B, after transfection with sie2f4-1, cells were collected at 0 or 24 h after IR, subjected to immunoprecipitation (as described in Fig. 2BCitation ), and analyzed by Western blot using anti-p130 antibody. C, untransfected cells (Lanes C) and those transfected with sigapdh (Lanes G) and sie2f4 (Lanes E4) were subjected to 10 Gy of IR and collected at 0 or 24 h. Immunoblotting was performed with anti-caspase-3, anti-poly(ADP-ribose) polymerase, and anti-ß-actin antibodies. D, cell viability was assayed using Hoechst (10 µg/ml) staining of cells treated with reagent (control) or those transfected with sigapdh or sie2f4, either unirradiated ({square}) or 24 h after IR (). Data points represent the mean of six readings, with error bars indicated (except for those that had three replicates). P values from Student’s t test comparison for the samples with equal variances are shown above the error bars. P values above the sigapdh bars are in comparison with the control, whereas values for the sie2f4 samples are in comparison with the sigapdh samples.

 
By inactivating E2F4 and E2F5 in mice, it was reported that at least one E2F4 or E2F5 functional allele was required for live birth and that these mice displayed major defects in the G1-phase control of the cell cycle (20) . To investigate the role of E2F4 expression on cell survival, we examined the activation of the caspase-mediated pathway, which is known to be critical for apoptosis in C4-2 cells (14) . After IR, the sie2f4-transfected cells (E4) exhibited decreased levels of the pro form of caspase-3, indicative of its proteolytic cleavage and activation (Fig. 4C)Citation . Moreover, there was a detectable p85 proteolytic cleavage product of poly(ADP-ribose) polymerase, a well-known caspase-3 substrate (14) . In contrast, these changes were not apparent in cells treated with reagent only or transfected with sigapdh. Levels of E2F4 were decreased by siRNA in control and irradiated cells; in the absence of siRNA, E2F4 levels were increased after IR. Finally, we determined the effect of E2F4 inactivation on cell survival (Fig. 4D)Citation . Examination of nuclear condensation, a hallmark of apoptosis, revealed that the untransfected cells and those transfected with sigapdh exhibited similar cell viability after IR. In contrast, C4-2 cells transfected with sie2f4 displayed a significant increase in nuclear condensation, which was further increased after IR, indicating that E2F4 inactivation renders C4-2 cells sensitive to IR-induced DNA damage.

In summary, we have shown that IR controls prostate tumor cell growth by increasing the expression of the E2F4 transcription factor in the nucleus and promoting its association with the p130 pocket protein. Our data indicate that the inactivation of E2F4 by siRNA prevents formation of the p130/E2F4 transcription complex and sensitizes cells to IR-induced apoptosis. Because E2F4 is overexpressed in prostate tumor epithelial cells (21) , it may provide a suitable target for effective radiation therapy. Additional studies will be needed to examine the specific contribution of critical genes to the radiation-resistant phenotype of C4-2 cells, whose expression is modulated after E2F4 inactivation.


    ACKNOWLEDGMENTS
 
We thank Dr. W. Heston (Cleveland Clinic) for the C4-2 cells and Dr. J. Drazba, A. Vasanji, and D. Leontiev (Imaging Core Facility) for fluorescence and confocal microscopy. We also thank Dr. J. Hissong for assistance with statistical analyses and M. Crosby and Dr. S. Ray for critical reading of the manuscript.


    FOOTNOTES
 
Grant support: NIH Grants CA81504 and CA82858.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Requests for reprints: Alexandru Almasan, Departments of Cancer Biology and Radiation Oncology, Lerner Research Institute, NB-40, Cleveland Clinic Foundation, Cleveland, OH 44195. Phone: (216) 444-9970; Fax: (216) 445-6269; E-mail: almasaa{at}ccf.org

Received 11/26/03. Revised 4/23/04. Accepted 5/19/04.


    REFERENCES
 Top
 ABSTRACT
 Introduction
 Materials and Methods
 Results and Discussion
 REFERENCES
 

  1. Greenlee RT, Murray T, Bolden S, Wingo PA. Cancer statistics, 2000. CA-Cancer J Clin, 50: 7-33, 2000.[Abstract]
  2. Fowler FJ, Jr, McNaughton Collins M, Albertsen PC, et al Comparison of recommendations by urologists and radiation oncologists for treatment of clinically localized prostate cancer. JAMA, 283: 3217-22, 2000.[Abstract/Free Full Text]
  3. Moberg K, Starz MA, Lees JA. E2F-4 switches from p130 to p107 and pRB in response to cell cycle reentry. Mol Cell Biol, 16: 1436-49, 1996.[Abstract]
  4. Trimarchi JM, Lees JA. Sibling rivalry in the E2F family. Nat Rev Mol Cell Biol, 3: 11-20, 2002.[CrossRef][Medline]
  5. Classon M, Harlow E. The retinoblastoma tumour suppressor in development and cancer. Nat Rev Cancer, 2: 910-7, 2002.[CrossRef][Medline]
  6. Black EP, Huang E, Dressman H, et al Distinct gene expression phenotypes of cells lacking Rb and Rb family members. Cancer Res, 63: 3716-23, 2003.[Abstract/Free Full Text]
  7. Farkas T, Hansen K, Holm K, Lukas J, Bartek J. Distinct phosphorylation events regulate p130- and p107-mediated repression of E2F-4. J Biol Chem, 277: 26741-52, 2002.[Abstract/Free Full Text]
  8. Bhattacharya S, Garriga J, Calbo J, et al SKP2 associates with p130 and accelerates p130 ubiquitylation and degradation in human cells. Oncogene, 22: 2443-51, 2003.[CrossRef][Medline]
  9. Gaubatz S, Lees JA, Lindeman GJ, Livingston DM. E2F4 is exported from the nucleus in a CRM1-dependent manner. Mol Cell Biol, 21: 1384-92, 2001.[Abstract/Free Full Text]
  10. Shiyanov P, Bagchi S, Adami G, et al p21 disrupts the interaction between cdk2 and the E2F-p130 complex. Mol Cell Biol, 16: 737-44, 1996.[Abstract]
  11. Almasan A, Yin Y, Kelly RE, et al Deficiency of retinoblastoma protein leads to inappropriate S-phase entry, activation of E2F-responsive genes, and apoptosis. Proc Natl Acad Sci USA, 92: 5436-40, 1995.[Abstract/Free Full Text]
  12. Haas-Kogan DA, Kogan SC, Levi D, et al Inhibition of apoptosis by the retinoblastoma gene product. EMBO J, 14: 461-72, 1995.[Medline]
  13. Thalmann GN, Anezinis PE, Chang SM, et al Androgen-independent cancer progression and bone metastasis in the LNCaP model of human prostate cancer. Cancer Res, 54: 2577-81, 1994.[Abstract/Free Full Text]
  14. Ray S, Almasan A. Apoptosis induction in prostate cancer cells and xenografts by combined treatment with Apo2L/TRAIL and CPT-11. Cancer Res, 63: 4713-23, 2003.[Abstract/Free Full Text]
  15. Mazumder S, Gong B, Almasan A. Cyclin E induction by genotoxic stress leads to apoptosis of hematopoietic cells. Oncogene, 19: 2828-35, 2000.[CrossRef][Medline]
  16. Sardet C, Vidal M, Cobrinik D, et al E2F-4 and E2F-5, two members of the E2F family, are expressed in the early phases of the cell cycle. Proc Natl Acad Sci USA, 92: 2403-7, 1995.[Abstract/Free Full Text]
  17. Gregory CW, He B, Johnson RT, et al A mechanism for androgen receptor-mediated prostate cancer recurrence after androgen deprivation therapy. Cancer Res, 61: 4315-9, 2001.[Abstract/Free Full Text]
  18. Hansen K, Farkas T, Lukas J, et al Phosphorylation-dependent and -independent functions of p130 cooperate to evoke a sustained G1 block. EMBO J, 20: 422-32, 2001.[CrossRef][Medline]
  19. Calbo J, Parreno M, Sotillo E, et al G1 cyclin/cyclin-dependent kinase-coordinated phosphorylation of endogenous pocket proteins differentially regulates their interactions with E2F4 and E2F1 and gene expression. J Biol Chem, 277: 50263-74, 2002.[Abstract/Free Full Text]
  20. Gaubatz S, Lindeman GJ, Ishida S, et al E2F4 and E2F5 play an essential role in pocket protein-mediated G1 control. Mol Cell, 6: 729-35, 2000.[CrossRef][Medline]
  21. Waghray A, Schober M, Feroze F, et al Identification of differentially expressed genes by serial analysis of gene expression in human prostate cancer. Cancer Res, 61: 4283-6, 2001.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
Cancer Res.Home page
S. A. Amundson, K. T. Do, L. C. Vinikoor, R. A. Lee, C. A. Koch-Paiz, J. Ahn, M. Reimers, Y. Chen, D. A. Scudiero, J. N. Weinstein, et al.
Integrating Global Gene Expression and Radiation Survival Parameters across the 60 Cell Lines of the National Cancer Institute Anticancer Drug Screen
Cancer Res., January 15, 2008; 68(2): 415 - 424.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
S. Ray, S. Shyam, G. C. Fraizer, and A. Almasan
S-phase checkpoints regulate Apo2 ligand/TRAIL and CPT-11-induced apoptosis of prostate cancer cells
Mol. Cancer Ther., April 1, 2007; 6(4): 1368 - 1378.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
R. S. Bindra, S. L. Gibson, A. Meng, U. Westermark, M. Jasin, A. J. Pierce, R. G. Bristow, M. K. Classon, and P. M. Glazer
Hypoxia-Induced Down-regulation of BRCA1 Expression by E2Fs
Cancer Res., December 15, 2005; 65(24): 11597 - 11604.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by DuPree, E. L.
Right arrow Articles by Almasan, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by DuPree, E. L.
Right arrow Articles by Almasan, A.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online